内皮细胞的功能上不同的抗凝剂机制
Claudia Schönichen1, Siyu Sun2, Harmen Middelveld2
1Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, the Netherlands; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University of Mainz, Germany.
内皮细胞通过抗血和组织因子通路抑制剂 (TFPI) 途径显著抑制血生成. 阻断这些通路会逆转抗凝剂效果,揭示了抑制血栓的附加机制.
科学领域:
- 生物医学科学 生物医学科学
- 血管生物学 血管生物学
- 血液静止和血栓形成
背景情况:
- 内皮细胞在调节血液凝固方面发挥着至关重要的作用.
- 抗血和组织因子通路抑制剂 (TFPI) 是关键的抗凝蛋白.
- 之前的研究在微流体模型中确定了内皮细胞的抗凝功能.
研究的目的:
- 研究由内皮细胞调节血栓生成的机制.
- 确定抗凝血素和TFPI在内皮细胞介导的抗凝血中的作用.
- 为了阐明内皮细胞使用的添加剂抗凝路途径.
主要方法:
- 在96孔板中利用内皮单层来研究血栓生成.
- 评估了全血,富血小板血和无血小板血的影响.
- 干预研究涉及阻断氨酸类蛋白质甘氨酸和TFPI,以及操纵抗血素水平.
- 采用了酶治疗 (肝激酶) 和特定抑制剂 (安德xanet-alpha,抗TFPI抗体).
主要成果:
- 内皮单层显著延迟和抑制组织因子诱导的血栓生成.
- 阻断氨酸类蛋白质甘氨酸或抗血素消除了抗凝效应.
- 肝酶治疗降低了内皮抗凝剂的潜力.
- 安德克萨内特-α和抗TFPI抗体逆转了内皮的抗凝剂作用.
结论:
- 内皮细胞通过添加机制产生强大的抗凝效应.
- 表面表达的氨酸类蛋白质甘氨酸和TFPI有助于抑制血栓.
- 这些发现凸显了内皮细胞在维持血静的复杂作用.
更多相关视频
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
06:27A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
Published on: November 21, 2014
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Paracrine Signaling
Regulation of Angiogenesis and Blood Supply
